ログイン

CLINICAL CHEMISTRY/

CLINICAL CHEMISTRY/
100問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Excitement "

    0.09-0.25

  • 2

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Confusion "

    0.18-0.30

  • 3

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Stupor "

    0.25-0.40

  • 4

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Coma "

    0.35-0.50

  • 5

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Death "

    0.45+

  • 6

    it is first converted to formaldehyde, then finally to formic acid in the liver

    Methanol

  • 7

    Methanol it is first converted to ?, then finally to ?in the liver

    formaldehyde; formic acid

  • 8

    causes BLINDNESS

    Methanol

  • 9

    Ethanol-like symptoms but LONGER DURATION

    Isopropanol (rubbing alcohol)

  • 10

    -sweet taste

    Ethylene Glycol

  • 11

    -Increase CaOx

    Ethylene Glycol

  • 12

    The sample of choice for measuring blood osmolality

    Serum

  • 13

    is useful for estimating the amount of ethanol present in the serum

    osmolal gap

  • 14

    No alcohol content

    ROOT BEER

  • 15

    -Silent killer (tasteless, colorless, odorless)

    Carbon monoxide

  • 16

    Cherry red face and blood

    Carbon monoxide

  • 17

    higher affinity for Hb (200 to 225x greater than O2)

    Carbon monoxide

  • 18

    ODOR OF BITTER ALMOND

    Cyanide

  • 19

    Binds to iron -> ATP depletion

    Cyanide

  • 20

    Classified as SUPERTOXIC substance

    Cyanide

  • 21

    inhibits sulfhydryl enzymes

    Arsenic

  • 22

    Distinct white lines in the fingernails “Mees’ Lines”

    Arsenic

  • 23

    odor of garlic” & “metallic taste

    Arsenic

  • 24

    What ELEMENT? Environmental pollutant

    Cadmium

  • 25

    destruction of type 1 epithelial cells in the lung

    Cadmium

  • 26

    disease is characterized by severe osteomalacia and osteoporosis from the longterm consumption of cadmium contaminated rice

    Itai itai

  • 27

    acquired through the following: Inhalation, ingestion, and skin contact

    Lead/plumbism

  • 28

    Animal bite is not included

    Lead/plumbism

  • 29

    Wrist drop or foot drop” manifestation

    Lead/plumbism

  • 30

    — reagent required to obtain the needed sensitivity and precision

    Triton X-100

  • 31

    Triton X-100 — reagent required to obtain the needed sensitivity and precision

    Lead/plumbism

  • 32

    Normal color urine but red fluorescence under wood’s lamp

    Lead/plumbism

  • 33

    has the ability to “amalgamate”

    Mercury

  • 34

    Mercury has the ability to “?”

    amalgamate

  • 35

    Rotten egg breath odor

    Sulfur

  • 36

    Garlic breath/petroleum odor

    Organophosphate poison

  • 37

    intentionally uses drugs that are unhealthy and illegal

    Drug of Abuse

  • 38

    the patient uses medicine that is not intended for him/her

    Misuse of drugs

  • 39

    cocaine, amphetamine, and morphine

    Alkaline drugs

  • 40

    Alkaline drugs

    cocaine, amphetamine, and morphine

  • 41

    referred to as “ecstasy”

    Methylenedioxymethamphetamine (MDMA)

  • 42

    Methylenedioxymethamphetamine (MDMA) referred to as “?”

    ecstasy

  • 43

    Tetrahydrocannabinol (THC) is the most potent component and most abundant

    Cannabinoids

  • 44

    Cannabinoids , Is the most potent component and most abundant

    Tetrahydrocannabinol (THC)

  • 45

    Metabolite: Benzoylecgonine

    Cocaine

  • 46

    Cocaine Metabolite:

    Benzoylecgonine

  • 47

    reagents used in Thin layer chromatography to extract cocaine metabolites from urine

    Alkali and organic solvent

  • 48

    Alkali and organic solvent used in ? to extract cocaine metabolites from urine

    Thin layer chromatography

  • 49

    Constriction of pupil — “pin-point pupils”

    Opiates

  • 50

    Angel dust/angel hair

    Phencyclidine

  • 51

    Panic reaction/bad trip

    LSD

  • 52

    - Certifies laboratories to conduct forensic drug testing for federal agencies

    SAMHSA Substance Abuse and Mental Health Services Administration

  • 53

    5 Panel drug test:

    MAP CO Marijuana Amphetamines PCP Cocaine Opiates

  • 54

    Acceptable range in QC

    95%

  • 55

    Chief plasma cation whose Chief plasma cation whose osmotic pressure a) Chloride b) Calcium c) Sodium d) Potassium

    c) Sodium

  • 56

    Rule that would be violated 1 out of 20 by chance

    12s

  • 57

    CICr is used to estimate the: a) Tubular secretion of creatinine b) Glomerular secretion of creatinine c) Renal glomerular and tubular mass d) Glomerular filtration rate

    d) Glomerular filtration rate

  • 58

    Six Sigma Process of Improvement

    DMAIC Define Measure Analyze Improve Control

  • 59

    Where is the thyroid gland located? a) lower anterior neck b) lower posterior neck c) upper anterior neck d) upper posterior neck

    a) lower anterior neck

  • 60

    Best for detecting all types of error

    Levy- jennings

  • 61

    the earliest indication of a shift or trend?

    CUSUM

  • 62

    best for comparison of precision and accuracy among laboratories

    Tonks-Youden

  • 63

    used to compare the means of two methods

    T-test

  • 64

    most useful in order to detect sample misidentification?

    Delta limit

  • 65

    Sample of choice for electrolyte testing: a) Whole blood b) Urine c) Plasma d) Serum

    c) Plasma

  • 66

    Which of the following total quality management tools can be used to calculate the analytical error rate for an analyte in the clinical laboratory? a. lean b. six sigma

    b. six sigma

  • 67

    Liver function tests are usually based on which principle? a) photometry b) turbidimetry c) nephelometry d) ISE

    a) photometry

  • 68

    considered a lipid? A. HDL B. LDL C. Chylomicron D. Cholesterol

    D. Cholesterol

  • 69

    Lead toxicity is acquired through the following EXCEPT: a) skin contact b) animal bite c) inhalation d) ingestion

    b) animal bite

  • 70

    Most important tool for assessing cardiac risk and important for therapeutic decision making A. HDL B. LDL

    B. LDL

  • 71

    First step in preanalytical phase? a) Test order b) Patient preparation c) Patient identification d) Patient collection

    a) Test order

  • 72

    1036 mg/dL TAG A. Pancreatitis B. Conary heart disease

    A. Pancreatitis

  • 73

    Not a physical hazard: a) Ergonomic b) Noise c) Non-ionizing radiation d) Aerosol

    d) Aerosol

  • 74

    Surrogate marker for HDL? A. Apo B100 B. Apo A1

    B. Apo A1

  • 75

    Amount of substance: a) Kg b)L c) Candela d) Mole

    d) Mole

  • 76

    12 hrs lipid panel A. Water is not allowed B. Water is allowed

    B. Water is allowed

  • 77

    3 uL is equivalent to _: a) 3E-6L b) 3E-9L c) 3E-12 L d) 0.003 L

    a) 3E-6L

  • 78

    What is the major excretory product of protein metabolism? a) Urea b) Ammonia c) Uric acid d) Creatinine

    a) Urea

  • 79

    A in PASS is: a) Alert b) Alarm c) Aim d) Activate

    c) Aim

  • 80

    The CLSI allows less vigorous studies to verify a reference interval with as few as__ subject specimens. a) 15 b) 20 c)25 d) 30

    b) 20

  • 81

    A new reference interval is established when there is no existing analyte or methodology in the reference laboratory with which to conduct comparative studies. It is costly and labor-intensive study that will involve laboratory resources at all levels and may require __ individuals a) 100 b) 110 c) 120 d) 130

    c) 120

  • 82

    A Gaussian distribution is usually a) Bell- shaped b) Rectangular c) Uniform d) Skewed

    a) Bell- shaped

  • 83

    At what serum concentration would glucose begin to appear in the urine? a) 50 mg/dL b) 75 mg/dL c) 100 mg/ dL d) 170 mg/dL

    d) 170 mg/dL

  • 84

    Which of the following would be most adversely affected by a nonfasting sample? a) HDL b) LDL c) Cholesterol d) Triglycerides

    d) Triglycerides

  • 85

    Which of the following apoproteins is inversely related to risk for coronary heart disease and is a surrogate marker for HDL? a) Apo A-l b) Apo B c) Apo B100 d) APOE

    a) Apo A-l

  • 86

    Where do steroids derived from? a) Glyceride b) Non glyceride c) Fatty acid d) Complex

    b) Non glyceride c) Fatty acid

  • 87

    Which of the following sets of values for repeat analyses of a QC sample (target value of 50) reflects the best precision? a) 50, 51, 52, b) 50, 52, 56 c) 48, 50, 52 d) 44, 50,53

    a) 50, 51, 52,

  • 88

    Which of the following would NOT be a typical methodology for a clinical chemistry test? a) Immunoturbidimetry b) Microscopy c) EMIT® d) ISE

    b) Microscopy

  • 89

    How should a laboratory verify the reference range it uses for a particular test? a) Call another laboratory b) Use the numbers from a textbook c) Test samples from healthy people d) Look ona medical internet site.

    c) Test samples from healthy people

  • 90

    Which test is the most specific for myocardial infarction? a) LDH is b) CK c) Troponin d) Myoglobin

    c) Troponin

  • 91

    Which of the following enzymes catalyzes the conversion of starch to glucose and maltose? a) Lipase b) Amylase c) ALT d) GGT

    b) Amylase

  • 92

    If a screening TSH is high, which test is likely to be ordered next? a) Cholesterol b) Free T4 c) Ferritin d) Glucose

    b) Free T4

  • 93

    The sample of choice for measuring blood osmolality: a) Serum b) Plasma c) Whole blood d) Urine

    a) Serum

  • 94

    A hormone that is also an enzyme a) Renin b) Vasopressin c) TSH d) Cortisol

    a) Renin

  • 95

    Buffer used in ALP analysis: a) Tris b) Acetic acid c) Hydrochloric acid d) Bicarbonate

    a) Tris

  • 96

    Used to calibrate pH meter: a) Distilled water b) Tap water c) Buffers d) Saline

    c) Buffers

  • 97

    NOT true of CRP a) Chronic Inflammation marker b) APR c) Plasma protein d) acute inflammatory marker

    a) Chronic Inflammation marker

  • 98

    What is 1440 in the Creatinine Clearance equation? a) Constant b) GFR c) Correction for body mass d) Average body surface

    a) Constant

  • 99

    Unit for urine creatinine: a) mL/min b) mg/dL ) g/dL d) g/L

    b) mg/dL

  • 100

    ADH secreted by the? a) Hypothalamus b) Anterior pituitary gland c) Posterior pituitary gland d) Adenohypophysis

    c) Posterior pituitary gland

  • HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Excitement "

    0.09-0.25

  • 2

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Confusion "

    0.18-0.30

  • 3

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Stupor "

    0.25-0.40

  • 4

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Coma "

    0.35-0.50

  • 5

    Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Death "

    0.45+

  • 6

    it is first converted to formaldehyde, then finally to formic acid in the liver

    Methanol

  • 7

    Methanol it is first converted to ?, then finally to ?in the liver

    formaldehyde; formic acid

  • 8

    causes BLINDNESS

    Methanol

  • 9

    Ethanol-like symptoms but LONGER DURATION

    Isopropanol (rubbing alcohol)

  • 10

    -sweet taste

    Ethylene Glycol

  • 11

    -Increase CaOx

    Ethylene Glycol

  • 12

    The sample of choice for measuring blood osmolality

    Serum

  • 13

    is useful for estimating the amount of ethanol present in the serum

    osmolal gap

  • 14

    No alcohol content

    ROOT BEER

  • 15

    -Silent killer (tasteless, colorless, odorless)

    Carbon monoxide

  • 16

    Cherry red face and blood

    Carbon monoxide

  • 17

    higher affinity for Hb (200 to 225x greater than O2)

    Carbon monoxide

  • 18

    ODOR OF BITTER ALMOND

    Cyanide

  • 19

    Binds to iron -> ATP depletion

    Cyanide

  • 20

    Classified as SUPERTOXIC substance

    Cyanide

  • 21

    inhibits sulfhydryl enzymes

    Arsenic

  • 22

    Distinct white lines in the fingernails “Mees’ Lines”

    Arsenic

  • 23

    odor of garlic” & “metallic taste

    Arsenic

  • 24

    What ELEMENT? Environmental pollutant

    Cadmium

  • 25

    destruction of type 1 epithelial cells in the lung

    Cadmium

  • 26

    disease is characterized by severe osteomalacia and osteoporosis from the longterm consumption of cadmium contaminated rice

    Itai itai

  • 27

    acquired through the following: Inhalation, ingestion, and skin contact

    Lead/plumbism

  • 28

    Animal bite is not included

    Lead/plumbism

  • 29

    Wrist drop or foot drop” manifestation

    Lead/plumbism

  • 30

    — reagent required to obtain the needed sensitivity and precision

    Triton X-100

  • 31

    Triton X-100 — reagent required to obtain the needed sensitivity and precision

    Lead/plumbism

  • 32

    Normal color urine but red fluorescence under wood’s lamp

    Lead/plumbism

  • 33

    has the ability to “amalgamate”

    Mercury

  • 34

    Mercury has the ability to “?”

    amalgamate

  • 35

    Rotten egg breath odor

    Sulfur

  • 36

    Garlic breath/petroleum odor

    Organophosphate poison

  • 37

    intentionally uses drugs that are unhealthy and illegal

    Drug of Abuse

  • 38

    the patient uses medicine that is not intended for him/her

    Misuse of drugs

  • 39

    cocaine, amphetamine, and morphine

    Alkaline drugs

  • 40

    Alkaline drugs

    cocaine, amphetamine, and morphine

  • 41

    referred to as “ecstasy”

    Methylenedioxymethamphetamine (MDMA)

  • 42

    Methylenedioxymethamphetamine (MDMA) referred to as “?”

    ecstasy

  • 43

    Tetrahydrocannabinol (THC) is the most potent component and most abundant

    Cannabinoids

  • 44

    Cannabinoids , Is the most potent component and most abundant

    Tetrahydrocannabinol (THC)

  • 45

    Metabolite: Benzoylecgonine

    Cocaine

  • 46

    Cocaine Metabolite:

    Benzoylecgonine

  • 47

    reagents used in Thin layer chromatography to extract cocaine metabolites from urine

    Alkali and organic solvent

  • 48

    Alkali and organic solvent used in ? to extract cocaine metabolites from urine

    Thin layer chromatography

  • 49

    Constriction of pupil — “pin-point pupils”

    Opiates

  • 50

    Angel dust/angel hair

    Phencyclidine

  • 51

    Panic reaction/bad trip

    LSD

  • 52

    - Certifies laboratories to conduct forensic drug testing for federal agencies

    SAMHSA Substance Abuse and Mental Health Services Administration

  • 53

    5 Panel drug test:

    MAP CO Marijuana Amphetamines PCP Cocaine Opiates

  • 54

    Acceptable range in QC

    95%

  • 55

    Chief plasma cation whose Chief plasma cation whose osmotic pressure a) Chloride b) Calcium c) Sodium d) Potassium

    c) Sodium

  • 56

    Rule that would be violated 1 out of 20 by chance

    12s

  • 57

    CICr is used to estimate the: a) Tubular secretion of creatinine b) Glomerular secretion of creatinine c) Renal glomerular and tubular mass d) Glomerular filtration rate

    d) Glomerular filtration rate

  • 58

    Six Sigma Process of Improvement

    DMAIC Define Measure Analyze Improve Control

  • 59

    Where is the thyroid gland located? a) lower anterior neck b) lower posterior neck c) upper anterior neck d) upper posterior neck

    a) lower anterior neck

  • 60

    Best for detecting all types of error

    Levy- jennings

  • 61

    the earliest indication of a shift or trend?

    CUSUM

  • 62

    best for comparison of precision and accuracy among laboratories

    Tonks-Youden

  • 63

    used to compare the means of two methods

    T-test

  • 64

    most useful in order to detect sample misidentification?

    Delta limit

  • 65

    Sample of choice for electrolyte testing: a) Whole blood b) Urine c) Plasma d) Serum

    c) Plasma

  • 66

    Which of the following total quality management tools can be used to calculate the analytical error rate for an analyte in the clinical laboratory? a. lean b. six sigma

    b. six sigma

  • 67

    Liver function tests are usually based on which principle? a) photometry b) turbidimetry c) nephelometry d) ISE

    a) photometry

  • 68

    considered a lipid? A. HDL B. LDL C. Chylomicron D. Cholesterol

    D. Cholesterol

  • 69

    Lead toxicity is acquired through the following EXCEPT: a) skin contact b) animal bite c) inhalation d) ingestion

    b) animal bite

  • 70

    Most important tool for assessing cardiac risk and important for therapeutic decision making A. HDL B. LDL

    B. LDL

  • 71

    First step in preanalytical phase? a) Test order b) Patient preparation c) Patient identification d) Patient collection

    a) Test order

  • 72

    1036 mg/dL TAG A. Pancreatitis B. Conary heart disease

    A. Pancreatitis

  • 73

    Not a physical hazard: a) Ergonomic b) Noise c) Non-ionizing radiation d) Aerosol

    d) Aerosol

  • 74

    Surrogate marker for HDL? A. Apo B100 B. Apo A1

    B. Apo A1

  • 75

    Amount of substance: a) Kg b)L c) Candela d) Mole

    d) Mole

  • 76

    12 hrs lipid panel A. Water is not allowed B. Water is allowed

    B. Water is allowed

  • 77

    3 uL is equivalent to _: a) 3E-6L b) 3E-9L c) 3E-12 L d) 0.003 L

    a) 3E-6L

  • 78

    What is the major excretory product of protein metabolism? a) Urea b) Ammonia c) Uric acid d) Creatinine

    a) Urea

  • 79

    A in PASS is: a) Alert b) Alarm c) Aim d) Activate

    c) Aim

  • 80

    The CLSI allows less vigorous studies to verify a reference interval with as few as__ subject specimens. a) 15 b) 20 c)25 d) 30

    b) 20

  • 81

    A new reference interval is established when there is no existing analyte or methodology in the reference laboratory with which to conduct comparative studies. It is costly and labor-intensive study that will involve laboratory resources at all levels and may require __ individuals a) 100 b) 110 c) 120 d) 130

    c) 120

  • 82

    A Gaussian distribution is usually a) Bell- shaped b) Rectangular c) Uniform d) Skewed

    a) Bell- shaped

  • 83

    At what serum concentration would glucose begin to appear in the urine? a) 50 mg/dL b) 75 mg/dL c) 100 mg/ dL d) 170 mg/dL

    d) 170 mg/dL

  • 84

    Which of the following would be most adversely affected by a nonfasting sample? a) HDL b) LDL c) Cholesterol d) Triglycerides

    d) Triglycerides

  • 85

    Which of the following apoproteins is inversely related to risk for coronary heart disease and is a surrogate marker for HDL? a) Apo A-l b) Apo B c) Apo B100 d) APOE

    a) Apo A-l

  • 86

    Where do steroids derived from? a) Glyceride b) Non glyceride c) Fatty acid d) Complex

    b) Non glyceride c) Fatty acid

  • 87

    Which of the following sets of values for repeat analyses of a QC sample (target value of 50) reflects the best precision? a) 50, 51, 52, b) 50, 52, 56 c) 48, 50, 52 d) 44, 50,53

    a) 50, 51, 52,

  • 88

    Which of the following would NOT be a typical methodology for a clinical chemistry test? a) Immunoturbidimetry b) Microscopy c) EMIT® d) ISE

    b) Microscopy

  • 89

    How should a laboratory verify the reference range it uses for a particular test? a) Call another laboratory b) Use the numbers from a textbook c) Test samples from healthy people d) Look ona medical internet site.

    c) Test samples from healthy people

  • 90

    Which test is the most specific for myocardial infarction? a) LDH is b) CK c) Troponin d) Myoglobin

    c) Troponin

  • 91

    Which of the following enzymes catalyzes the conversion of starch to glucose and maltose? a) Lipase b) Amylase c) ALT d) GGT

    b) Amylase

  • 92

    If a screening TSH is high, which test is likely to be ordered next? a) Cholesterol b) Free T4 c) Ferritin d) Glucose

    b) Free T4

  • 93

    The sample of choice for measuring blood osmolality: a) Serum b) Plasma c) Whole blood d) Urine

    a) Serum

  • 94

    A hormone that is also an enzyme a) Renin b) Vasopressin c) TSH d) Cortisol

    a) Renin

  • 95

    Buffer used in ALP analysis: a) Tris b) Acetic acid c) Hydrochloric acid d) Bicarbonate

    a) Tris

  • 96

    Used to calibrate pH meter: a) Distilled water b) Tap water c) Buffers d) Saline

    c) Buffers

  • 97

    NOT true of CRP a) Chronic Inflammation marker b) APR c) Plasma protein d) acute inflammatory marker

    a) Chronic Inflammation marker

  • 98

    What is 1440 in the Creatinine Clearance equation? a) Constant b) GFR c) Correction for body mass d) Average body surface

    a) Constant

  • 99

    Unit for urine creatinine: a) mL/min b) mg/dL ) g/dL d) g/L

    b) mg/dL

  • 100

    ADH secreted by the? a) Hypothalamus b) Anterior pituitary gland c) Posterior pituitary gland d) Adenohypophysis

    c) Posterior pituitary gland